Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
03 2019
Historique:
received: 18 04 2018
revised: 27 05 2018
accepted: 15 06 2018
pubmed: 1 8 2018
medline: 4 1 2020
entrez: 1 8 2018
Statut: ppublish

Résumé

To assess differential patterns of axonal loss and demyelination in the optic nerve in multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). Cross-sectional study. One hundred ninety-two participants, including 136 MS patients (272 eyes), 19 NMOSD patients (38 eyes), and 37 healthy control participants (74 eyes). All participants underwent spectral-domain OCT scans and multifocal visual evoked potential (mfVEP) recordings. High-resolution magnetic resonance imaging (MRI) with the diffusion protocol also was performed in all patients. Ganglion cell-inner plexiform layer (GCIPL) thickness and mfVEP amplitude and latency at 5 eccentricities; global and temporal retinal nerve fiber layer thickness. In optic neuritis (ON) eyes, the NMOSD patients had more severe GCIPL loss (P < 0.001) and mfVEP amplitude reduction (P < 0.001) compared with MS patients, whereas in contrast, mfVEP latency delay was more evident in MS patients (P < 0.001). The NMOSD patients showed more morphologic and functional loss at the foveal to parafoveal region, whereas the MS patients showed evenly distributed damage at the macula. Correlation analysis demonstrated a strong structure-function (OCT-mfVEP) association in the NMOSD patients, which was only moderate in the MS patients. In non-ON (NON) eyes, the MS patients showed significantly thinner GCIPL than controls (P < 0.001), whereas no GCIPL loss was observed in NON eyes in NMOSD. In addition, a significant correlation was found between all OCT and mfVEP measures in MS patients, but not in NMOSD patients. MRI demonstrated significant lesional load in the optic radiation in MS compared to NMOSD eyes (P = 0.002), which was related to the above OCT and mfVEP changes in NON eyes. Our study demonstrated different patterns of ON damage in NMOSD and MS. In MS, the ON damage was less severe, with demyelination as the main pathologic component, whereas in NMOSD, axonal loss was more severe compared with myelin loss. The disproportional mfVEP amplitude and latency changes suggested predominant axonal damage within the anterior visual pathway as the main clinical feature of NMOSD, in contrast to MS, where demyelination spreads along the entire visual pathway.

Identifiants

pubmed: 30060979
pii: S0161-6420(18)30508-6
doi: 10.1016/j.ophtha.2018.06.022
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-453

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Ting Shen (T)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.

Yuyi You (Y)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia; Save Sight Institute, The University of Sydney, Sydney, Australia. Electronic address: yuyi.you@gmail.com.

Sukanya Arunachalam (S)

Save Sight Institute, The University of Sydney, Sydney, Australia.

Ariadna Fontes (A)

Australia Department of Neurology, Royal North Shore Hospital, Sydney, Australia.

Sidong Liu (S)

Save Sight Institute, The University of Sydney, Sydney, Australia; Brain and Mind Centre, The University of Sydney, Sydney, Australia.

Vivek Gupta (V)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.

John Parratt (J)

Australia Department of Neurology, Royal North Shore Hospital, Sydney, Australia.

Chenyu Wang (C)

Brain and Mind Centre, The University of Sydney, Sydney, Australia; Sydney Neuroimaging Analysis Centre, Sydney, Australia.

Michael Barnett (M)

Brain and Mind Centre, The University of Sydney, Sydney, Australia; Sydney Neuroimaging Analysis Centre, Sydney, Australia.

Joshua Barton (J)

Brain and Mind Centre, The University of Sydney, Sydney, Australia.

Nitin Chitranshi (N)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.

Ling Zhu (L)

Save Sight Institute, The University of Sydney, Sydney, Australia.

Clare L Fraser (CL)

Save Sight Institute, The University of Sydney, Sydney, Australia.

Stuart L Graham (SL)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia; Save Sight Institute, The University of Sydney, Sydney, Australia.

Alexander Klistorner (A)

Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia; Save Sight Institute, The University of Sydney, Sydney, Australia; Brain and Mind Centre, The University of Sydney, Sydney, Australia.

Con Yiannikas (C)

Australia Department of Neurology, Royal North Shore Hospital, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH